US4968629A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Blood diluent for automatic and semi-automatic determination of white cells and method of utilizing same
Assignee: Bio Rad Laboratories Inc
•
Filing: 1987-12-16
•
Granted: 1990-11-06
•
Expires: 2007-12-16
Abstract
Abstract A universal blood diluent for use in hematology analysis is the subject of this invention. The diluent consists of an aqueous solution of 0.4-1.5% by weight of either Na 2 SO 4 or NaNO 3 or a combination of the two. Also included is 0.1-0.4% by weight of a salt of the formula XH 2 PO 4 where X is either Na or K and 0.1-2.4% by weight of a salt of the formula X 2 HPO where X is Na or K. The phosphate salts may be hydrous or anhydrous. A mixture of Na and K phosphate salts may also been employed. The salts should be present in a ratio of from 1:1 to 1:6 (by weight), XH 2 PO 4 :X 2 HPO 4 . 0.1 to 1% by weight of one or both of NaCl and KCl is also included. The Na 2 SO 4 and NaNO 3 should be present in a ratio of at least 1:1 (by weight) relative to the chloride salt. The pH of the diluent should be within the range of 6.0-8.0 and it should have an osmotic strength of 200-400 milliosmoles. The diluent may be used in either automated or semi-automated analytical equipment. The use of an inorganic buffer offers numerous advantages over prior art organic buffers including cost an better performance. The diluent allows for leukocyte analysis as well as maintaining erythrocyte morphology until a lysing reagent is introduced.
Inventors
- 👤 James D. Lapicola
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 01:03
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/96; G01N33/5005; G01N33/5094; Y; Y10; Y10T; Y10T436/00; Y10T436/10; Y10T436/107497; Y10T436/108331
Claims Analysis
Total Claims: 25
Claim 1
Independent Claim
114 words
A diluent for use in leukocyte analysis which maintains erythrocyte morphology consisting of an aqueous solution of: 0.4 to 1.5% by weight of one or more of the group consisting of Na 2 SO 4 and NaNO 3 ; 0.01 to 0.4% by weight of a salt of the formula XH 2 PO 4 , hydrous or anhydrous, where X is either Na or K; 0.01 to 0.6% by weight of a salt of the formula X 2 HPO 4 , hydrous or anhydrous, where X is either Na or K, said phosphate salts being present in a ratio of from 1:1 to 1:6 XH 2 PO 4 :X 2 HPO 4 ; and
Claim 2
Dependent Claim
114 words
A diluent for use in leukocyte analysis which maintains erythrocyte morphology consisting of an aqueous solution of: 0.4 to 1.5% by weight of one or more of the group consisting of Na 2 SO 4 and NaNO 3 ; 0.01 to 0.4% by weight of a salt of the formula XH 2 PO 4 , hydrous or anhydrous, where X is either Na or K; 0.01 to 0.6% by weight of a salt of the formula X 2 HPO 4 , hydrous or anhydrous, where X is either Na or K, said phosphate salts being present in a ratio of from 1:1 to 1:6 XH 2 PO 4 :X 2 HPO 4 ; and
Claim 3
Dependent Claim
42 words
01 to 1% by weight of one or both of NaCl and KCl, said member of the group consisting of NaSO 4 and NaNO 3 being present in a ratio of at least 1:1 (by weight) relative to the NaCl and KCl.
Claim 4
Dependent Claim
42 words
01 to 1% by weight of one or both of NaCl and KCl, said member of the group consisting of NaSO 4 and NaNO 3 being present in a ratio of at least 1:1 (by weight) relative to the NaCl and KCl.
Claim 5
Independent Claim
131 words
A method of preparing a whole blood sample for leukocyte determination while maintaining erythrocyte morphology comprising the steps of: supplying a whole blood sample; supplying a diluent consisting of an aqueous solution of: 0.4 to 1.5% by weight of one or more of the group consisting of Na 2 SO 4 and NaNO 3 ; 0.01 to 0.4% by weight of a salt of the formula XH 2 PO 4 , hydrous or anhydrous, where X is either Na or K; 0.01 to 0.6% by weight of a salt of the formula X 2 HPO 4 , hydrous or anhydrous, where X is either Na or K, said phosphate salts being present in a ratio of from 1:1 to 1:6 (by weight) XH 2 PO 4 :X 2 HPO 4 ,
Claim 6
Independent Claim
131 words
A method of preparing a whole blood sample for leukocyte determination while maintaining erythrocyte morphology comprising the steps of: supplying a whole blood sample; supplying a diluent consisting of an aqueous solution of: 0.4 to 1.5% by weight of one or more of the group consisting of Na 2 SO 4 and NaNO 3 ; 0.01 to 0.4% by weight of a salt of the formula XH 2 PO 4 , hydrous or anhydrous, where X is either Na or K; 0.01 to 0.6% by weight of a salt of the formula X 2 HPO 4 , hydrous or anhydrous, where X is either Na or K, said phosphate salts being present in a ratio of from 1:1 to 1:6 (by weight) XH 2 PO 4 :X 2 HPO 4 ,
Claim 7
Dependent Claim
69 words
01 to 1% by weight of one or both of NaCl and KCl, said member of the group consisting of NaSO 4 and NaNO 3 being present in a ratio of at least 1:1 (by weight) relative to the NaCl and KCl; mixing the whole blood and the diluent for a first analytical step; and adding a lysing reagent to the diluted whole blood sample for subsequent analytical steps.
Claim 8
Dependent Claim
69 words
01 to 1% by weight of one or both of NaCl and KCl, said member of the group consisting of NaSO 4 and NaNO 3 being present in a ratio of at least 1:1 (by weight) relative to the NaCl and KCl; mixing the whole blood and the diluent for a first analytical step; and adding a lysing reagent to the diluted whole blood sample for subsequent analytical steps.
Claim 9
Independent Claim
154 words
A method for determining the relative populations of at least the lymphocytes and granulocytes in a whole blood sample utilizing an automatic particle analyzing system, said method comprising the steps of: supplying a whole blood sample to said system; supplying a diluent for use in leukocyte analysis which maintains erythrocyte morphology consisting of an aqueous solution of: 0.4 to 1.5% by weight of one or more of the group consisting of Na 2 SO 4 and NaNO 3 ; 0.01 to 0.4% by weight of a salt of the formula XH-hd 2PO 4 , hydrous or anhydrous, where X is either Na or K; 0.01 to 0.6% by weight of a salt of the formula X 2 HPO 4 , hydrous or anhydrous, where X is either Na or K, said phosphate salts being present in a ratio of from 1:1 to 1:6 (by weight) XH 2 PO 4 :X 2 HPO 4 ;
Claim 10
Independent Claim
154 words
A method for determining the relative populations of at least the lymphocytes and granulocytes in a whole blood sample utilizing an automatic particle analyzing system, said method comprising the steps of: supplying a whole blood sample to said system; supplying a diluent for use in leukocyte analysis which maintains erythrocyte morphology consisting of an aqueous solution of: 0.4 to 1.5% by weight of one or more of the group consisting of Na 2 SO 4 and NaNO 3 ; 0.01 to 0.4% by weight of a salt of the formula XH-hd 2PO 4 , hydrous or anhydrous, where X is either Na or K; 0.01 to 0.6% by weight of a salt of the formula X 2 HPO 4 , hydrous or anhydrous, where X is either Na or K, said phosphate salts being present in a ratio of from 1:1 to 1:6 (by weight) XH 2 PO 4 :X 2 HPO 4 ;
Claim 11
Dependent Claim
124 words
01 to 1% by weight of one or both of NaCl and KCl, said member of the group consisting of NaSO 4 and NaNO 3 being present in a ratio of at least 1:1 (by weight) relative to the NaCl and KCl; mixing the whole blood sample and the diluent for a first analytical step; and mixing the whole blood sample and the diluent within the analyzing system with a lysing reagent thereby resulting in volumetric modification of the individual blood cells forming at least the lymphocyte and granulocyte subpopulations of leukocytes for a significant period of time to enable the automatic differentiation of these subpopulations by the analyzing system, said lysing reagent comprising an aqueous solution of one or more quaternary ammonium salts.
Claim 12
Dependent Claim
124 words
01 to 1% by weight of one or both of NaCl and KCl, said member of the group consisting of NaSO 4 and NaNO 3 being present in a ratio of at least 1:1 (by weight) relative to the NaCl and KCl; mixing the whole blood sample and the diluent for a first analytical step; and mixing the whole blood sample and the diluent within the analyzing system with a lysing reagent thereby resulting in volumetric modification of the individual blood cells forming at least the lymphocyte and granulocyte subpopulations of leukocytes for a significant period of time to enable the automatic differentiation of these subpopulations by the analyzing system, said lysing reagent comprising an aqueous solution of one or more quaternary ammonium salts.
Claim 13
Dependent Claim
115 words
A diluent for use in leukocyte analysis which maintains erythrocyte morphology consisting of an aqueous solution of: 0.4 to 1.5% by weight of one or more of the group consisting of Na 2 SO 4 and NaNO 3 ; 0.01 to 0.4% by weight of a salt of the formula XH 2 PO 4 , hydrous or anhydrous, where X is either Na or K; 0.01 to 0.6% by weight of a salt of the formula X 2 HPO 4 , hydrous or anhydrous, where X is either Na or K, said phosphate salts being present in a ratio of from 1:1 to 1:6 (by weight) XH 2 PO 4 :X 2 HPO 4 ;
Claim 14
Dependent Claim
115 words
A diluent for use in leukocyte analysis which maintains erythrocyte morphology consisting of an aqueous solution of: 0.4 to 1.5% by weight of one or more of the group consisting of Na 2 SO 4 and NaNO 3 ; 0.01 to 0.4% by weight of a salt of the formula XH 2 PO 4 , hydrous or anhydrous, where X is either Na or K; 0.01 to 0.6% by weight of a salt of the formula X 2 HPO 4 , hydrous or anhydrous, where X is either Na or K, said phosphate salts being present in a ratio of from 1:1 to 1:6 (by weight) XH 2 PO 4 :X 2 HPO 4 ;
Claim 15
Dependent Claim
51 words
01 to 1% by weight of one or both of NaCl and KCl, said member of the group consisting of NaSO 4 and NaNO 3 being present in a ration of at least 1:1 (by weight) relative to the NaCl and KCl; and a bacteria inhibiting effective quantity of a bacteriostat.
Claim 16
Dependent Claim
51 words
01 to 1% by weight of one or both of NaCl and KCl, said member of the group consisting of NaSO 4 and NaNO 3 being present in a ration of at least 1:1 (by weight) relative to the NaCl and KCl; and a bacteria inhibiting effective quantity of a bacteriostat.
Claim 17
Dependent Claim
22 words
A diluent as set forth in claim 4 wherein said bacteriostat is present in a quantity of up to 0.5% by weight.
Claim 18
Dependent Claim
30 words
A diluent as set forth in claim 4 wherein said bacteriostat is selected from the group consisting of 1-hydroxypyridene-2-thione, 8-quinolinol, 8-quinolinol citrate, 8-hydroxyquinaldine (2-methyl-8-quinolinol), 8-hydroxyquinoline-5-sulfonic acid-dihydrate, and 8-hydroxy-5-nitroquinoline, and merthiolate.
Claim 19
Independent Claim
207 words
A method of preparing a whole blood sample for leukocyte determination while maintaining erythrocyte morphology comprising the steps of: supplying a whole blood sample; supplying a diluent consisting of an aqueous solution of: 0.4 to 1.5% by weight of one or more of the group consisting of Na 2 SO 4 and NaNO 3 ; 0.01 to 0.4% by weight of a salt of the formula XH 2 PO 4 , hydrous or anhydrous, where X is either Na or K; 0.01 to 0.6% by weight of a salt of the formula X 2 HPO 4 , hydrous or anhydrous, where X is either Na or K, said phosphate salts being present in a ratio of from 1:1 to 1:6 (by weight) XH 2 PO 4 :X 2 HPO 4 , 0.01 to 1% by weight of one or both of NaCl and KCl, said member of the group consisting of NaSO 4 and NaNO 3 being present in a ratio of at least 1:1 (by weight) relative to the NaCl and KCl; a bacteria inhibiting quantity of a bacteriostat; mixing the whole blood and the diluent for a first analytical step; and adding a lysing reagent to the diluted whole blood sample for subsequent analytical steps.
Claim 20
Independent Claim
207 words
A method of preparing a whole blood sample for leukocyte determination while maintaining erythrocyte morphology comprising the steps of: supplying a whole blood sample; supplying a diluent consisting of an aqueous solution of: 0.4 to 1.5% by weight of one or more of the group consisting of Na 2 SO 4 and NaNO 3 ; 0.01 to 0.4% by weight of a salt of the formula XH 2 PO 4 , hydrous or anhydrous, where X is either Na or K; 0.01 to 0.6% by weight of a salt of the formula X 2 HPO 4 , hydrous or anhydrous, where X is either Na or K, said phosphate salts being present in a ratio of from 1:1 to 1:6 (by weight) XH 2 PO 4 :X 2 HPO 4 , 0.01 to 1% by weight of one or both of NaCl and KCl, said member of the group consisting of NaSO 4 and NaNO 3 being present in a ratio of at least 1:1 (by weight) relative to the NaCl and KCl; a bacteria inhibiting quantity of a bacteriostat; mixing the whole blood and the diluent for a first analytical step; and adding a lysing reagent to the diluted whole blood sample for subsequent analytical steps.
Claim 21
Dependent Claim
20 words
A method as set forth in claim 7, wherein said lysing reagent comprises a 1 to 6% by weight solution.
Claim 22
Dependent Claim
30 words
A method as set forth in claim 7 wherein said bacteriostat is selected from the group consisting of 1-hydroxypyridene-2-thione, 8-quinolinol, 8-quinolinol citrate, 8-hydroxyquinaldine (2-methyl-8-quinolinol), 8-hydroxyquinoline-5-sulfonic acid-dihydrate, and 8-hydroxy-5-nitroquinoline, and merthiolate.
Claim 23
Independent Claim
286 words
A method for determining the relative populations of at least the lymphocytes and granulocytes in a whole blood sample utilizing an automatic particle analyzing system, said method comprising the steps of: supplying a whole blood sample to said system; supplying a diluent for use in leukocyte analysis which maintains erythrocyte morphology consisting of an aqueous solution of: 0.4 to 1.5% by weight of one or more of the group consisting of Na 2 SO 4 and NaNO 3 ; 0.01 to 0.4% by weight of a salt of the formula XH 2 PO 4 , hydrous or anhydrous, where X is either Na or K; 0.01 to 0.6% by weight of a salt of the formula X 2 HPO 4 , hydrous or anhydrous, where X is either Na or K. said phosphate salts being present in a ratio of from 1:1 to 1:6 (by weight) XH 2 PO 4 :X 2 HPO 4 ; 0.01 to 1% by weight of one or both of NaCl and KCl, said member of the group consisting of NaSO 4 and NaNO 3 being present in a ratio of at least 1:1 (by weight) relative to the NaCl and KCl; a bacteria inhibiting quantity of a bacteriostat; mixing the whole blood sample and the diluent for a first analytical step; and mixing the whole blood sample and the diluent within the analyzing system with a lysing reagent thereby resulting in volumetric modification of the individual blood cells forming at least the lymphocyte and granulocyte subpopulations of leukocytes for a significant period of time to enable the automatic differentiation of these subpopulations by the analyzing system, said lysing reagent comprising an aqueous solution of one or more quaternary ammonium salts.
Claim 24
Independent Claim
286 words
A method for determining the relative populations of at least the lymphocytes and granulocytes in a whole blood sample utilizing an automatic particle analyzing system, said method comprising the steps of: supplying a whole blood sample to said system; supplying a diluent for use in leukocyte analysis which maintains erythrocyte morphology consisting of an aqueous solution of: 0.4 to 1.5% by weight of one or more of the group consisting of Na 2 SO 4 and NaNO 3 ; 0.01 to 0.4% by weight of a salt of the formula XH 2 PO 4 , hydrous or anhydrous, where X is either Na or K; 0.01 to 0.6% by weight of a salt of the formula X 2 HPO 4 , hydrous or anhydrous, where X is either Na or K. said phosphate salts being present in a ratio of from 1:1 to 1:6 (by weight) XH 2 PO 4 :X 2 HPO 4 ; 0.01 to 1% by weight of one or both of NaCl and KCl, said member of the group consisting of NaSO 4 and NaNO 3 being present in a ratio of at least 1:1 (by weight) relative to the NaCl and KCl; a bacteria inhibiting quantity of a bacteriostat; mixing the whole blood sample and the diluent for a first analytical step; and mixing the whole blood sample and the diluent within the analyzing system with a lysing reagent thereby resulting in volumetric modification of the individual blood cells forming at least the lymphocyte and granulocyte subpopulations of leukocytes for a significant period of time to enable the automatic differentiation of these subpopulations by the analyzing system, said lysing reagent comprising an aqueous solution of one or more quaternary ammonium salts.
Claim 25
Dependent Claim
30 words
A method as set forth in claim 10 wherein said bacteriostat is selected from the group consisting of 1-hydroxypyridene-2-thione, 8-quinolinol, 8-quinolinol citrate, 8-hydroxyquinaldine (2-methyl-8-quinolinol), 8-hydroxyquinoline-5-sulfonic acid-dihydrate, and 8-hydroxy-5-nitroquinoline, and merthiolate.
References Cited (Backward Citations)
US3962125A
Cited
US4102810A
Cited
US4213876A
Cited
US4506018A
Cited
US4529705A
Cited
US4617275A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-11-05 | 1994-05-07 | 1994-11-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-11-05 | 1998-05-07 | 1998-11-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-11-05 | 2002-05-07 | 2002-11-06 | $7700.00 | Window Closed / Lapsed |